GO
Loading...

Novartis pipeline faces tough competition

Tuesday, 22 Oct 2013 | 4:00 AM ET

Andrew Weiss, head of pharma and biotech research at Vontobel, says most products in Novartis' pipeline will face tough competition and incur large marketing costs.